Myocardial Solutions

About Myocardial Solutions

Myocardial Solutions, Inc. (MSI) is a medical technology firm focused on the cardio-oncology and preventive cardiology markets. Founded in 2002 by Dr. Nael Osman, the company originated from technology he developed as a professor at Johns Hopkins University. Dr. Osman, an accomplished researcher in cardiac MRI technology with over 60 scientific papers, pioneered the techniques that form the basis of the company's core product.

The company's flagship offering is MyoStrain®, a non-invasive cardiac imaging software. This technology is designed to detect subtle changes in heart function before symptoms appear, a critical factor in managing patients undergoing treatments known for cardiotoxicity, like chemotherapy. MyoStrain completes a heart scan in under 10 minutes, utilizing an MRI to quantify myocardial function across 48 distinct segments of the heart without requiring contrast agents or radiation. The system generates a comprehensive report that includes the MyoHealth™ Score, a single metric representing the percentage of normally functioning heart muscle, which helps clinicians track cardiac health over time.

MSI's business model centers on providing its MyoStrain software to hospitals, cancer centers, and diagnostic imaging facilities. By forming strategic partnerships, such as one with United Imaging, MSI offers a complete package that includes financing, installation, and training for dedicated cardiac MR scanners equipped with their software. This approach targets the growing cardio-oncology market, estimated to be a $2.8 billion annual testing market, by offering a solution that can differentiate a cancer center's services. The company's technology has received FDA 510(k) clearance and CE-mark certification, enabling its commercial use in the United States and Europe. Clients include prominent institutions like the Mayo Clinic, Ackerman Cancer Center, and various hospitals in Spain and Germany.